Platelets store large amounts of serotonin that they release during thrombus formation or acute inflammation. This facilitates hemostasis and modulates the inflammatory response.
I
mmediate restoration of blood flow by coronary intervention improves the survival of patients with myocardial infarction (MI). Targeting the deleterious processes during subsequent reperfusion injury holds the promise of further reducing the final infarct size and hence limiting heart failure in survivors. 1 The initial phase of reperfusion is characterized by ionic imbalance and distortion of the Na + /Ca 2+ and Na + /H + exchangers, leading to mitochondrial damage and hypercontraction of the myocardium. 2, 3 Microembolization, production of reactive oxygen species, and instability of vessel wall integrity further threaten myocardial recovery. 4 Finally, excessive leukocyte recruitment into the affected myocardium occurs in the early hours after reperfusion (neutrophils are the predominant invaders during the first 24 hours). 5 The effect of neutrophil infiltration on outcome appears to follow a U-shaped curve with an optimum of modest neutrophil recruitment benefiting postinfarction healing, while excessive infiltration is detrimental, because neutrophils aggravate reperfusion injury. 6 Mitigating the excess of neutrophil infiltration may restrict reperfusion injury while maintaining the beneficial healing process.
For transmigration through the vessel wall into inflamed tissues, neutrophils interact with activated endothelial cells directly 7 or under the influence of platelet-mediated cell-cell communication. 8 Endothelial selectins mediate neutrophil tethering and rolling, followed by integrin-mediated firm cell adhesion that allows for subsequent transmigration. 9 Interfering with selectin and integrin function reduced experimental myocardial reperfusion injury, illustrating the relevance of inflammatory cell recruitment and the potential of pharmacological intervention. 10 We recently reported that platelet-derived serotonin (5-hydroxytryptamine, 5-HT) enhanced the recruitment of neutrophils to sites of acute inflammation and tissue damage. 11 However, the underlying mechanism remained elusive. In the context of MI and coronary intervention, observational studies proposed that the depletion of platelet serotonin stores by long-term administration of serotonin reuptake inhibitors (a side-effect of many antidepressants) may improve outcome after MI and vasomotion post percutaneous coronary intervention (PCI). 12 We hypothesized that platelet serotonin aggravates myocardial reperfusion injury by promoting excessive neutrophil recruitment.
Indeed, serotonin induced exocytosis of neutrophil granules, thereby increasing the surface expression of the β2-integrin CD11b, mediating cell adhesion to platelets and the endothelium, and releasing myeloperoxidase (MPO) and hydrogen peroxide (H 2 O 2 ), which altogether impaired healing after myocardial infarction. 13 
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. All data, methods, materials are available on personal request at the Department of Cardiology and Angiology I, Heart Center, University of Freiburg(contact: daniel.duerschmied@universitaets-herzzentrum.de).
A detailed section of all used methods is available in the online version of this manuscript.
Animals
Ten to 12-week-old tryptophan hydroxylase-1-deficient (Tph1 −/− ) mice were kindly provided by Michael Bader from the Max-Delbrück-Center for Molecular Medicine (Berlin, Germany). Wild type (WT) littermates of heterozygous breeding were on a C57BL/6 N background. All mice were housed in the local animal facility. All experiments were conducted strictly according to the German animal protection law and in accordance with good animal practice as defined by the Federation of Laboratory Animal Science Associations (www. felasa.eu) and the national animal welfare body GV-SOLAS (www.gv-solas.de). The examinations undertaken in this study were approved by the federal authorities in Freiburg and the Institutional Review Board.
Murine Model of Myocardial Ischemia Reperfusion
All surgeries were performed between 10 am and 2 pm to avoid circadian rhythm-associated irregularities according to recently published guidelines for experimental models of myocardial ischemia and infarction.
14 Briefly, WT and
Clinical Perspective
What Is New?
• Markers of neutrophil degranulation correlate with plasmatic serotonin levels in acute coronary syndrome patients.
• Neutrophils express serotonin receptors 5HT4 and 5HT7.
• Platelet-derived serotonin triggers neutrophil degranulation.
• Genetic or pharmacological depletion of serotonin in platelets protects from myocardial ischemia and reperfusion injury.
What Are the Clinical Implications?
• Platelet-derived serotonin stimulating neutrophil infiltration, degranulation, and oxidative burst represents a druggable target to mitigate the inflammatory burden in myocardial ischemia and reperfusion injury.
• Inhibiting serotonin uptake into platelets of patients treated for depression reduced neutrophil degranulation even under otherwise healthy conditions, indicating that the platelet serotonin-neutrophil axis is of relevance to humans and modifiable. 
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Tph1 −/− mice were anesthetized by intraperitonially injection of 80 mg/kg ketamine (Ketavet; Pfizer Pharmacia, Berlin, Germany) and 4,8 mg/kg xylazine (Rompun; Bayer Vital, Leverkusen, Germany). Analgesia was provided by subcutaneous injection of 125 µg/kg buprenorphine. To avoid dehydration, 500 µL warm 0.9% NaCl (9 mg/mL) containing 5% glucose (G5; B.Braun Melsungen, Melsungen, Germany) was injected intraperitonially. Mice were placed on a heating pad to maintain body temperature at 37°C. The operation table was tilted 20% to allow visualization of the vocal cords and mice were intubated under sight. Ventilation was set to a maximal end-inspiratory pressure of 10 cm H 2 O, at a respiratory rate of 110 breaths per minute, and an inspiration/expiration ratio of 1/1.5 with a small-animal respirator (TSE Systems, Bad Homburg, Germany). Oxygen saturation, heart rate, and respiratory rate were monitored throughout the procedure by a MouseOX system (Starr Life Sciences, Oakmont, Pennsylvania). Anesthesia was maintained by addition of 1.2% isoflurane (Abbott, Wiesbaden, Germany) during surgery. After right lateral positioning of the animal, left lateral thoracotomy was performed and the left anterior descending (LAD) coronary artery was identified. To induce ischemia an 8.0 nylon suture (Prolene; Ethicon, Norderstedt, Germany) was placed around the vessel and a loose loop was formed. A fine bore 0.61-mm polythene tube was placed on the LAD and the loop was tied. Ligation was visually confirmed by paling of the left ventricular anterior wall. The tube was removed after 30 minutes to allow reperfusion of myocardium indicated by a bright red color within the LAD. After evacuation of the pneumothorax chest and skin wounds were closed using a 6-0 Prolene suture (Ethicon, Norderstedt, Germany). Mice were monitored until spontaneous breathing occurred and placed under a heating lamp. A second dose of buprenorphine was administered 10 hours after surgery.
Determination of Infarct Size
Hearts were excised 24 hours after surgery and placed in a petri dish containing 0.9% NaCl (B.Braun Melsungen, Melsungen, Germany) solution; the aorta was cannulated using a 22-gauge safety intravenous catheter with injection port (Vasofix Safety; B.Braun Melsungen, Melsungen, Germany) and fixated using a 6-0 Prolene suture. Ligation was reestablished by placing a polythene tube under the existing knot. Hearts were perfused with warm NaCl to remove any blood residues for 5 minutes by gravity flow. Then, 200 µL 5% MONOLITE Blue (Heubach, Langelsheim, Germany) diluted in 0.9% NaCl containing household detergent was injected into the system via a 3-way cock to visualize affected myocardium. Hearts were frozen at −20°C for 10 minutes afterward and cut in 5 to 7 1-mm sections using a cold razor blade. Slices were put in phosphate buffer (0.2 mol/L Na 2 HPO 4 / 0.2 mol/L NaH 2 PO 4 , adjusted to pH 7.4) containing 1% triphenyltetrazolium chloride (Sigma-Aldrich Chemie, Steinheim, Germany) and incubated in a water bath set to 37°C for 15 minutes. Necrotic tissue appeared white and healthy myocardium was stained red. Heart sections were placed on a cover slip, embedded with 5% agarose and covered with a second slip. Slices were photographed from both sides using an EOS 1000D camera (Canon Deutschland, Krefeld, Germany) under a Stemi 2000-C binocular (Carl Zeiss, Oberkochen, Germany).
Infarct size was calculated as the percentage of necrotic tissue in relation to nonmonolite blue area with ImageJ software.
Echocardiography
Mice were anesthetized by 2% isoflurane intransally and placed on a heating pad. Chest hair was removed using an electric shaver and animals were fixated on the back. Echocardiography loops were recorded in B and M modes in longitudinal and short axis views on a Vevo 3100 equipped with a MX550D transducer (both FUJIFILM VisualSonics, Inc., Toronto, Ontario, Canada). Mice were fixed on a heated table and heart rate was monitored during the procedure. Systole and diastole were defined based on concomitant electrocardiography (ECG) recordings. The end-systolic time point for left ventricular (LV) diameter measurement was defined as the maximum of ventricle contraction just before complete closure of the aortic valve. End-diastole was defined as the maximum of LV dilation and filling just before mitral valve closing (when visible) and aortic valve opening. LV ejection fraction (LVEF) was determined by LV tracing relating end systolic LV area as the minimal LV cross-sectional area to end-diastolic LV area as the maximum LV cross-sectional area in long axis views. Fractional shortening (FS) was assessed from short axis M-mode using VevoLab software (FUJIFILM VisualSonics).
Quantitative Real-Time Polymerase Chain Reaction
Quantitative real-time polymerase chain reaction was performed using TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific, Braunschweig, Germany) or IQ SYBR Green Supermix (Bio-Rad Laboratories, München, Germany) on a C1000 Touch Thermal Cycler (Bio-Rad Laboratories). Samples were amplified using An overview of used Taqman probes (Table I in the online-only Data Supplement) or oligonucleotides (Table II in the online-only Data Supplement). Data were statistically analyzed using the 2 −▵▵Ct method.
Flow Cytometry

Murine Blood Samples
Blood from WT ant Tph1 −/− mice was obtained by cardiac puncture using a 30-gauge needle coated with unfractionated heparin (B. Braun Melsungen, Melsungen, Germany). Then, 10 µL were incubated with 190 µL lysis buffer (BD Bioscience, Heidelberg, Germany) for 5 minutes and leukocytes were counted in a Neubauer chamber. Blood was immediately transferred to an Eppendorf tube containing 1.5 µg/µL enoxaparin (Sanofi Aventis, Frankfurt, Germany) in 50 µL PBS containing 0.9 mmol/L calcium, 0.5 mmol/L magnesium, and 0.1% BSA (PBS+/+, BSA). For in vitro stimulation, blood was incubated with either vehicle, or 100 µmol/L 5-hydroxytryptamine (5-HT, serotonin; Sigma-Aldrich CHEMIE, Steinheim, Germany) for 15 minutes, as previously described. [15] [16] [17] [18] Platelet rich plasma (PRP) was prepared as described above. Samples were diluted 1:6 in 37°C warm PBS. Ninety microliters diluted blood or PRP was mixed with 10 µL antibody mix and incubated for 15 minutes in the dark at room temperature. Stained whole blood samples were mixed gently with 400 µL 37°C To evaluate leukocyte subsets, platelet neutrophil complexes, integrin, and selectin expression after 24 hours of reperfusion, the following antibodies were used in 1:16 dilution in PBS+/+, BSA: anti-CD41-PECy7 (clone MWReg30), anti-CD42d-PerCPCy5.5 (clone 1C2), anti-CD45. 2 
Human Blood Samples
Whole blood from healthy volunteers, depressed patients, and patients suffering from acute coronary syndrome (ACS) was obtained by peripheral venous puncture. Blood was drawn from ACS patients on the day after percutaneous intervention. ACS patients and patients with depression gave written informed consent as approved by the Institutional Review Board of the University Hospital of Freiburg: 287/12, and 18/11_160618, respectively. In a separate experiment, neutrophils of healthy volunteers were isolated from whole blood using Polymorphprep (Axis-Shield, Rodelokka, Norway) according to manufacturer's protocol. For in vitro stimulation blood was incubated with either vehicle, or 100 µmol/L 5-hydroxytryptamine for 15 minutes at room temperature. For receptor blocking experiments blood was incubated with 100 µmol/L of a 5-HT receptor antagonist (5HTR 4 : SB207266; 5HTR 7 : SB269970; both Sigma-Aldrich Chemie, Steinheim, Germany) before stimulation. Blood was diluted 1:6 in warm Flow Cytometry buffer and 90 µL were stained with 10 µL antibody mix and incubated for 15 minutes in the dark at room temperature. Stained whole blood samples were mixed gently with 400 µL 37°C warm 1X Phosflow Lyse/Fix buffer (BD Bioscience, Heidelberg, Germany) and incubated for 30 minutes at room temperature. Data were acquired on a BD FACSCanto II and analyzed with FlowJo v10 software. Antibody mix to analyze platelet neutrophil complex (PNC) content, integrin, and selectin expression contained 1:16 dilution of the following monoclonal antibodies in PBS+/+, BSA: anti-CD41-PECy7 (clone HIP8), anti-CD45-APCCy7 (clone HI30), anti-CD66b-PerCP/Cy5.5 (clone G10F5), anti CD182-APC (clone 5E8/CXCR2), anti CD162-PE (clone KPL-1), anti-CD11a/CD18-AlexaFluor 488 (clone m24), anti-CD62L-BrilliantViolet 421 (clone DREG-56), anti-CD11a-PECy7 (clone HI111), and anti-CD11b-AlexaFluor 488 (clone ICRF44; all BioLegend, Fell, Germany).
Statistical Analysis
Experimental results are presented as mean values±SEM. One-way ANOVA with post hoc Tukey multiple comparisons test was performed when comparing >2 groups. Two-way ANOVA with Bonferroni multiple comparisons testing was used when more than 2 groups and variables were compared. Repeated measures ANOVA was used when the observations were not independent. Paired t test was used when samples were split and analyzed under various conditions. Pearson correlation analysis, Fisher exact test, Mann-Whitney U test or Student t test were used as indicated. P values from multiple t tests were adjusted using the Holm-Sidak method. Adjusted P values of ≤0.05 denote significant changes. Statistics were calculated using GraphPad Software.
RESULTS
Platelet Serotonin Aggravated Myocardial Ischemia and Reperfusion Injury
Myocardial infarction was induced by temporary coronary artery ligation in mice. At baseline serotonin plasma levels were low (73.5±8.7 ng/mL), but surged within 24 hours after 30 minutes of myocardial ischemia with subsequent reperfusion in WT mice (153.3±31.3 ng/ mL; Figure 1A ). In blood, serotonin is stored in platelets at millimolar concentrations and is quickly released on their activation, which raises serotonin levels from nanomolar (in resting plasma) to micromolar concentrations (locally in vivo during thrombosis or inflammation or in vitro in serum preparations). 19, 20 Tryptophan hydroxylase-1-deficient mice (Tph1 −/− ) are devoid of serotonin in blood, and platelets in particular, while serotonin levels in the central nervous system remain unaffected 21 ( Figure 1A ). When Tph1 -/-mice were subjected to myocardial ischemia with reperfusion, the infarct size was significantly reduced by about 35% compared to WT controls (36.4±2.4 versus 55.3±3.2% area at risk [AAR]; Figure 1B ). In line, echocardiography documented less compromised left ventricular (LV) function early on and up to 3 weeks post-MI in Tph1 -/-mice (~ 40% relative preservation of ejection fraction on d2 and 25% improved ejection fraction on d7; Figure 1C ; Table III in online-only Data Supplement). Moreover, inflammatory gene expression of MPO (-65.3±19%), tumor necrosis factor-α (TNFα; -59.8±16%), and chemokine keratinocyte chemoattractant (-48.5±16%) were reduced in the infarcts of Tph1 -/-mice. The changes were considered significant between groups for MPO and TNFα after multiple comparisons testing ( Figure 1D ; Table I in the online-only Data Supplement).
Platelet Serotonin Promoted Myocardial Neutrophil Infiltration
Neutrophils have previously been recognized as decisive promoters of myocardial reperfusion injury.
1, 22 We con- 
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firmed that neutrophils were the most abundant immune cell population within the left ventricle at 24 hours post-infarction (44.8±5.4% of leukocytes in WT controls; Figure 2A ). Coinciding with reduced infarct size, we found fewer neutrophils within the infarcted tissue of Tph1 -/-mice as compared to WT controls (13.9±1.5 versus 27.1±2.7 per mm 2 infarct area; Figure 2A and 2B) while their numbers in the blood, spleen, and bone marrow did not differ significantly ( Figure 2C ). Monocyte counts in the infarct, blood, spleen and bone marrow were similar between the groups, pointing toward a mechanism that influenced neutrophil infiltration, in particular ( -/-mice were perfused ex vivo in the absence of circulating leukocytes and subjected to myocardial ischemia with reperfusion, both loss in cardiac function and cardiomyocyte viability were comparable in both groups ( Figure II in the online-only Data Supplement). We concluded that the deleterious effects of platelet serotonin on myocardial reperfusion injury mainly depended on neutrophil influx.
Serotonin Increased Integrin Alpha-M Surface Expression on Neutrophils
Platelets can directly interact with neutrophils to form complexes. 23, 24 PNC formation in blood and heart doubled in WT mice 24 hours after myocardial reperfusion −▵▵Ct values by unpaired t tests, and asterisks denote significant differences according to correction for multiple comparisons using the Holm-Sidak method.
Circulation. Figure 3A and 3B). Platelet monocyte complex formation however was similar in both groups ( Figure IE in the online-only Data Supplement). Interestingly, surface expression of CD11b on neutrophils was significantly increased in WT mice compared to Tph1 -/-mice, with CD11b (integrin alpha-M, α-subunit of Mac-1) known to mediate leukocyte adhesion to endothelial cells and platelets 19, 25 ( Figure 3C ; Figure 
Serotonin-Induced Degranulation of Neutrophils
Neutrophil stimulation with serotonin increased CD11b surface expression both in WT and Tph1 -/-mice, thereby normalizing CD11b levels in the knockout animals (Figure 4A) . In contrast, CD11b surface expression in monocytes was similar in both groups before and after incubation with serotonin ( Figure 4B ). These observations pointed to a neutrophil-specific and inducible serotonin effect. Identification of several serotonin receptors, most notably subtype 4 and 7, on isolated neutrophils suggested that neutrophils were able to respond to serotonin, directly ( Figure 4C ; Table II in 27 Flow cytometric staining after membrane permeabilization documented that most of the neutrophil's CD11b was stored intracellularly. Tph1 -/-mice showed similar total CD11b protein levels to those in wild type mice while CD11b surface expression was relatively reduced by trend ( Figure 4D ). These data suggested that serotonin engaged in granule release in neutrophils. Consequently, stimulation of cultured blood neutrophils with serotonin did not only increase CD11b surface expression but also lipocalin-2 and MPO levels in the supernatants ( Figure 4E) . We also detected a release of hydrogen peroxide (H 2 O 2 ), a highly reactive oxidative burst product, on stimulation ( Figure 4E ). Conversely, inhibition of granule release by treatment with protein transport inhibitors brefeldin A and monensin abolished the rise of CD11b in wild type and Tph1 -/-mice ( Figure 4A ). Comparing electron microscopic images of neutrophils before and after stimulation with serotonin, we were able to visualize and quantify the disposal of azurophilic (45.9±3.9 versus 35.6±2.3) and specific granules (64.1±3.5 versus 35.2±4.8; Figure 4F ). Taken together, our data indicate a critical role for platelet serotonin in the regulation of neutrophil degranulation.
Platelet Serotonin Depletion by Fluoxetine Protected From Myocardial Ischemia Reperfusion Injury
We wondered whether we could phenocopy our observations made in Tph1 
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etine (Flx) for 3 weeks. The long-term SSRI treatment (mimicking SSRI treatment of patients with depression) resulted in a near complete depletion of serotonin stores in platelets ( Figure 5A ). Consequently, plasma serotonin remained at baseline in Flx treated mice even after myocardial ischemia with reperfusion ( Figure 5B ). Serotonin depletion resulted in a decreased PNC frequency with lower surface expression of CD11b on neutrophils, and reduced plasma MPO levels post MI ( Figure 5D and 5E). Surface expression of CD11a and other adhesion molecules did not change and circulating platelets showed a decrease of activation markers with SSRI treatment similar to that observed in Tph1 -/-mice ( Figure VIA and VIB in the online-only Data Supplement). Lastly, infarct size (39.9±1.9 versus 56.4±2.8% AAR) and heart function (20.2±0.7 versus 12.6±0.5% FS) improved with SSRI treatment (Figure 5F and 5G). P2Y12 inhibitors are routinely used in the acute treatment of MI and have been described to limit myocardial ischemia and reperfusion injury. 28, 29 We tested whether this protection was at least partly mediated by preventing the release of serotonin from platelets during myocardial infarction ( Figure 
Plasma Serotonin Correlated With the Neutrophil Release of CD11b and MPO in ACS Patients
In accord with our findings in mice, human neutrophils showed strong upregulation of CD11b surface expression and elevated plasma MPO levels on stimulation with serotonin in vitro. These effects were reversed by blocking the 5HT receptor subtype 7, specifically (Figure In patients with acute coronary syndrome (see Table IV in the online-only Data Supplement for demographics), CD11b surface expression and plasmatic MPO concentration strongly correlated with serotonin levels in plasma (Pearson r=0.846, r=0.6606, and r=0.516, respectively), while no significant correlations were observed for CD11a, CD62L, PSGL-1, and CXCR2 (Figure 6B through 6D; Figure VIIID in the online-only Data Supplement). Of note, all patients studied had been treated with aspirin plus a P 2 Y 12 inhibitor for at least 24 hours before blood sampling. Conversely, in patients with depression, longterm SRI use suppressed plasma serotonin levels, and reduced neutrophil CD11b expression significantly and MPO levels by trend ( Figure 6E ) compared to controls (Table V in the online-only Data Supplement). We concluded that activated platelets released serotonin during myocardial ischemia and reperfusion injury leading to the release of secretory granules containing CD11b and MPO in neutrophils. Elevated CD11b surface expression supported platelet neutrophil complex formation and cell adhesion to the endothelium while MPO aggravated inflammation ( Figure 7 ). Taken together, long-term fluoxetine treatment, an inducible model of platelet serotonin depletion in adult WT mice, phenocopied Tph1 -/-mice that underwent temporary LAD ligation with respect to CD11b and MPO release and protection from experimental myocardial ischemia and reperfusion injury. Our clinical data suggest that similar mechanisms operate in humans.
DISCUSSION
Serotonin is well known as a neurotransmitter and modulator of vasomotion. [30] [31] [32] Platelets are the dominant store of serotonin outside the nervous system and discharge serotonin on activation. Coronary artery disease and myocardial infarction provide a platelet-stimulating microenvironment that leads to the release of serotonin from platelets. 33 We identified thrombin and TLR4 ligands, but not ADP, as stimulators of serotonin release. In particular, younger patients with coronary artery disease and high serotonin levels are at increased risk for future cardiovascular events. 34 Mechanistically, serotonin was thought to promote platelet aggregation and vasoconstriction of diseased coronary arteries and influence cardiomyocyte function and survival. 35, 36 Experimental studies in animals investigating the role of serotonin in myocardial ischemia and reperfusion injury yielded conflicting results, which has, to date, prevented a successful translation into clinical studies. 33, 37 Discrepancies may have originated from different experimental setups, different animal models, and most notably, different serotonin receptor antagonists being investigated.
In an early study, the 5-HT 2 receptor antagonist LY53857 did not influence infarct size after 90 minutes of ligation of the left circumflex coronary artery followed by 5 hours of reperfusion in living dogs. 38 In contrast, the combined Ca 2+ and 5-HT 2 receptor antagonist nexopamil reduced infarct size by 55% after 1 hour of LAD ligation and 3 hours of reperfusion in living minipigs. 39 While LY53857 rather increased ex vivo reperfusion injury of isolated rat hearts perfused with platelets in an experimental setup with 15 minutes global ischemia followed by 10 minutes of reperfusion, 40 several 5-HT 2 receptor antagonists reduced ex vivo reperfusion injury of rat hearts after 25 minutes of ischemia and 30 minutes of reperfusion. 41 Circulating serotonin levels were significantly increased after 30 minutes of myocardial ischemia in living rabbits, as well as in isolated rabbit hearts, and treatment with the 5-HT 2A receptor antagonist sarpogrelate reduced infarct size by 32% (after 48 hours of reperfusion) in a more recent study. 33 We report now the first study on myocardial reperfusion injury investigating platelet serotonin depletion in mice. 
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Transient ischemia of ex vivo perfused hearts of Tph1 -/-mice devoid of peripheral serotonin did not affect the loss in cardiac function in the absence of circulating cells, while neutrophil depletion in vivo completely abolished the platelet serotonin-mediated aggravation of reperfusion injury.
Intrigued by these neutrophil-dependent effects, we identified platelet-derived serotonin as a potent stimulator of neutrophils in vitro and in vivo. We provided several lines of evidence that serotonin-induced degranulation in neutrophils increased the surface expression of granule-stored CD11b 27,42 and the release of MPO known to enhance tissue damage in concert with reactive oxygen species.
13,43 First, we found that serotonin elicits CD11b, but not CD11a, surface expression in neutrophils, but not monocytes, as CD11a is not stored in intracellular granules 44 and monocytes are almost devoid of those. Second, vesicle transport inhibition blocked the increase of CD11b surface expression. Third, electron microscopy of neutrophils directly visualized the depletion of intracellular granules on serotonin stimulation. The prompt and gradual increase of CD11b surface expression in neutrophils resembled degranulation kinetics reported for other granule-derived mediators such as MPO, CD66b, lactoferrin, lysozyme, gelatinase, and neutrophil gelatinase-associated lipocalin. 45 Interestingly, the P 2 Y 12 antagonist ticagrelor inhibited platelet activation and lowered CD11b surface expression on neutrophils as well. However, these inhibitory effects were independent from serotonin. Serotonin depletion resulted in an additional reduction in CD11b expression. Our data indicate that neutrophil degranulation is nonredundantly controlled by several stimuli, of which serotonin is being described in this work for the first time.
We discovered several serotonin receptor subtypes on neutrophils, most prominently 5-HT 4 and 5-HT 7 . Neutrophil degranulation depends on intracellular calcium increase that is typically mediated by chemokine/ cytokine-induced G protein-coupled receptor signaling. 46 Direct serotonin effects on neutrophil degranulation have not been described before. However, serotonin has been shown to stimulate Ca 2+ influx and intracellular Ca 2+ mobilization in vascular smooth muscle cells both via G protein coupled/IP 3 -dependent (eg, 5-HT 2 receptor subset) and cAMP/PKA-dependent (eg, 5-HT 4-7 receptor subsets) signaling pathways. 18, 47 We demonstrated that serotonin stimulated neutrophil degranulation via the receptor subtype 7 in humans.
Increased CD11b surface expression renders neutrophils more effective in adhering to the activated endothelium, the extracellular matrix, 7, 25 and to plate- 19 Consequently, lack of platelet serotonin resulted in reduced numbers of PNC and neutrophil deposition in the injured heart. Our findings are in line with previous reports suggesting that limiting neutrophil influx protected from myocardial reperfusion injury. 48 Serotonin has further been shown to aggravate other neutrophil-dependent inflammatory diseases like arthritis, endotoxic shock, asthma, or viral hepatitis, 11, 49, 50 but the cellular mechanisms have not been completely evaluated.
Finally, we verified that long-term SSRI treatment emptied platelet serotonin stores, providing us with an inducible model of peripheral serotonin deficiency in adult mice. Long-term SSRI treatment protected from myocardial reperfusion injury similar to TPH1 deficiency, resulting in a comparable reduction in CD11b surface expression in neutrophils. Intriguingly, SSRI treatment protected from myocardial ischemia/reperfusion injury even on top of P 2 Y 12 inhibition, which is an essential part of standard of care for ACS patients, clinically, and was reported to limit myocardial ischemia/reperfusion injury, experimentally in rats and rabbits. 28, 29 Platelets, our data suggest, govern neutrophil responses in serotonin-dependent and -independent pathways. Wholesome platelet depletion, however, may offset the protection conferred by selective serotonin depletion and P 2 Y 12 inhibition in exchange for bleeding complications and is not a viable option in practice. 29 We therefore advocate for targeting undesirable platelet effects in MI, such as those mediated by serotonin, while preserving beneficial ones. This view is supported by clinical data showing that chronic SSRI use was associated with fewer cardiovascular events in patients with depression. 12 Thus, we extended our experimental studies to humans. We confirmed the stimulatory effects of serotonin on CD11b surface expression and MPO release in human neutrophils mediated via the 5HT 7 receptor. Elevated plasma serotonin levels correlated with neutrophil CD11b surface expression and MPO plasma levels in patients with acute coronary syndrome. Platelet serotonin depletion in noncardiac patients treated with SSRI for their depression, we showed, suppressed CD11b expression and MPO levels.
Thus, we identified a novel mode of platelet-neutrophil crosstalk during myocardial ischemia and reperfusion injury that is relevant to humans: platelets secrete serotonin to promote degranulation of neutrophils with Serotonin released by platelets triggers the degranulation of neutrophils, subsequently leading to increased CD11b surface expression. This enhances circulating platelet neutrophil complex levels and supports the accumulation of proinflammatory cytokine-releasing neutrophils within the injured myocardium.
